Bacterial Vaginosis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for bacterial vaginosis. 20 active patents protecting 2 drugs from 2+ originators. First major cliff: 2035. Daily refresh.

2
Approved drugs
20
Active US patents
62/100
Avg vulnerability
—
Annual revenue covered

Originators in Bacterial Vaginosis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Evofem Inc 11 patents Baxter 9 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating bacterial vaginosis. Each bar = one year. Y-axis scaled to peak year (10 patents).

3
28
4
32
10
35
2
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Solosec
SECNIDAZOLE
 Evofem Inc 11 65 — 2035-09-04
Metro I.V. In Plastic Container
METRONIDAZOLE
 Baxter 9 58 — 2028-02-02

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8658678 Metro I.V. In Plastic Container method of use 75 2028-06-27
12257236 Metro I.V. In Plastic Container method of use 75 2039-01-16
12280037 Solosec method of use 75 2041-12-11
11602522 Solosec method of use 70 2035-09-04
11324721 Solosec method of use 70 2035-09-04
11684607 Solosec method of use 70 2035-09-16
8946276 Metro I.V. In Plastic Container method of use 62 2032-06-28
9198858 Metro I.V. In Plastic Container method of use 62 2032-06-28
10857133 Solosec method of use 62 2035-09-04
10849884 Solosec method of use 62 2035-09-04

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10238634 Metro I.V. In Plastic Container formulation 42 2032-06-28
10596155 Metro I.V. In Plastic Container formulation 42 2032-06-28
11541035 Metro I.V. In Plastic Container formulation 50 2039-10-04
7893097 Metro I.V. In Plastic Container formulation 55 2028-02-19
8877792 Metro I.V. In Plastic Container formulation 55 2028-02-02
11000508 Solosec method of use 62 2035-09-04
10682338 Solosec method of use 62 2035-09-04
11020377 Solosec method of use 62 2035-09-04
10335390 Solosec method of use 62 2035-09-04
10857133 Solosec method of use 62 2035-09-04

Related